Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Blade Therapeutics | Series Unknown | Undisclosed | South San Francisco, United States |
| 152 | Pinnacle Hill | Series Unknown | $65.0M | England, Germany |
| 153 | Poseidon Innovation | Series Unknown | $65.0M | San Diego, United States |
| 154 | Lakeside Discovery | Series Unknown | $65.0M | New York, United States |
| 155 | Ancora Innovation | Series Unknown | $65.0M | New York, United States |
| 156 | Braeburn | Debt Financing | $110.0M | Plymouth Meeting, United States |
| 157 | Concert Genetics | Series Unknown | Undisclosed | Franklin, United States |
| 158 | Vensun Pharmaceuticals | Series C | $22.5M | Yardley, United States |
| 159 | Recovery Centers of America | Private Equity | $100.0M | King Of Prussia, United States |
| 160 | TESARO | Post Ipo Equity | $409.0M | Waltham, United States |
Blade Therapeutics is a discovery stage drug development company.
Pinnacle Hill is the drug spinout company.
Poseidon Innovation is a provider of advance disease curing therapeutics for risky early-stage processes.
Lakeside Discovery accelerates the translation of transformative biomedical technologies.
Company that will support Vanderbilt’s innovative life science research .
We transform the management of OUD to help people begin and sustain recovery.
Concert Genetics provides physicians with the information they need to find the right test for their patients.
Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms.
Recovery Centers of America is fundamentally transforming the treatment of addiction and the capabilities of those in recovery
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
New American Therapeutics is a specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas.
Deerfield has invested in 161 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Health Care, Pharmaceutical, Therapeutics, Biotechnology, Medical. The firm invests across 11 different industry categories.
Among tracked funding rounds, TESARO received $409.0M in a Post Ipo Equity round. Deerfield's total known invested capital is $8.0B.
Deerfield's average investment size is $78.0M across its portfolio of 161 companies.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors